Skip to Content
Merck

Key Documents

View All Documentation

647829

PAMAM dendrimer, cystamine core, generation 2.0 solution

20 wt. % in methanol

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Linear Formula:
[NH2CH2CH2SSCH2CH2NH2]:(G=2);dendri PAMAM(NH2)16
Molecular Weight:
3348.36
UNSPSC Code:
12162002
NACRES:
NA.23
MDL number:
MFCD06798772
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

description

amino surface groups

Quality Level

100

form

liquid

mol wt

generation 2

feature

core type cystamine core

concentration

20 wt. % in methanol

no. Surface Groups

16

bp

64.7 °C

density

0.860 g/mL at 25 °C

storage temp.

−20°C

Packaging

unit weight includes solvent

Legal Information

For research use only

Disclaimer

Supply conditions do not apply to the regions and states of Brazil: North, Northeast, Mato Grosso do Sul, Mato Grosso, and Rio Grande do Sul.

signalword

Danger

Hazard Classifications

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1

target_organs

Eyes

Storage Class

3 - Flammable liquids

wgk

WGK 3

flash_point_f

49.5 °F - closed cup

flash_point_c

9.7 °C - closed cup

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
02424JJ
01719PH
11126EC

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Huang, B. H., Tomalia, D. A.
Journal of Luminescence, 111, 215-223 (2005)
DeMattei, C. R., Huang, B. H., Tomalia, D. A.
Nano Letters, 4, 771-777 (2004)
Anouk Zaal et al.
Frontiers in immunology, 11, 305-305 (2020-03-13)
Many tumors display alterations in the biosynthetic pathways of glycosylation, resulting in increased expression of specific tumor-associated glycan structures. Expression of these altered glycan structures is associated with metastasis and poor prognosis. Antigen presenting cells can recognize tumor-associated glycan structures